Physician profile
Heather Bergmann
NPI 1972181501
$2,620.08
in general payments reported to CMS, 2019-2025
7 companies · $916 in 2025
The $916 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.25 · 2022: $711 · 2023: $628 · 2024: $304 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,754 · Education: $92.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,754.45 |
| Education | $92.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,164.58 | 2021-2025 | Rybrevant, Carvykti, Tecvayli |
| E.R. Squibb & Sons, L.L.C. | $639.42 | 2022-2023 | Opdivo |
| Gilead Sciences, INC. | $350.11 | 2023-2025 | Trodelvy |
| Incyte Corporation | $129.84 | 2025 | Jakafi |
| Daiichi Sankyo INC. | $126.32 | 2025 | Vanflyta |
| Global Blood Therapeutics, INC. | $110.72 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $99.09 | 2023 | Calquence |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Bergmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.